Literature DB >> 25268586

Psoriatic inflammation facilitates the onset of arthritis in a mouse model.

Mayuko Yamamoto1, Kimiko Nakajima1, Mikiro Takaishi1, Shun Kitaba2, Yasuhiro Magata3, Sayo Kataoka4, Shigetoshi Sano5.   

Abstract

Psoriatic arthritis (PsA) is a seronegative, inflammatory joint disease associated with psoriasis. In most patients with PsA, skin lesions precede arthritis; however, the causality of skin inflammation for the development of arthritis remains unclear. Gp130F759/F759 knock-in (F759) mice develop autoimmune arthritis after 1 year of age through persistent signal transducer and activator of transcription 3 (Stat3) activation due to impairment in SOCS3-dependent negative regulation. Here, we crossed F759 mice with K5.Stat3C transgenic mice, in which keratinocytes express constitutive active Stat3 (Stat3C), leading to generation of psoriasis-like skin change. F759 mice harboring the K5.Stat3C transgene not only had aggravated skin lesions but also spontaneously developed arthritis with high penetrance in adjacent paws as early as 3 weeks of age. The joint lesions included swelling of the peripheral paws and nail deformities contiguous with the skin lesions, closely resembling PsA. Histopathologic study revealed enthesitis and bone erosions, with mononuclear cell infiltrates. Quantitative reverse transcriptase-PCR (RT-PCR), immunohistochemical analyses, and flow cytometry showed upregulation of the IL-23/T helper type 17 (Th17) pathway in affected joints. Furthermore, enforced generation of psoriasis-like skin inflammation by topical treatment with 12-O-tetradecanoylphorbol-13-acetate (TPA) in F759 mice induced swelling of the underlying joints. This animal model renders psoriatic inflammation as the driver of arthritis and helps to further understand the pathogenesis of PsA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25268586     DOI: 10.1038/jid.2014.426

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  45 in total

1.  Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model.

Authors:  Shigetoshi Sano; Keith Syson Chan; Steve Carbajal; John Clifford; Mary Peavey; Kaoru Kiguchi; Satoshi Itami; Brian J Nickoloff; John DiGiovanni
Journal:  Nat Med       Date:  2004-12-12       Impact factor: 53.440

2.  Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses.

Authors:  T Ohtani; K Ishihara; T Atsumi; K Nishida; Y Kaneko; T Miyata; S Itoh; M Narimatsu; H Maeda; T Fukada; M Itoh; H Okano; M Hibi; T Hirano
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

Review 3.  Anti-cytokine therapies for psoriasis.

Authors:  Kristine E Nograles; James G Krueger
Journal:  Exp Cell Res       Date:  2011-02-04       Impact factor: 3.905

Review 4.  Th17 cytokines and arthritis.

Authors:  Erik Lubberts
Journal:  Semin Immunopathol       Date:  2010-02-04       Impact factor: 9.623

5.  Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

Authors:  Lam C Tsoi; Sarah L Spain; Jo Knight; Eva Ellinghaus; Philip E Stuart; Francesca Capon; Jun Ding; Yanming Li; Trilokraj Tejasvi; Johann E Gudjonsson; Hyun M Kang; Michael H Allen; Ross McManus; Giuseppe Novelli; Lena Samuelsson; Joost Schalkwijk; Mona Ståhle; A David Burden; Catherine H Smith; Michael J Cork; Xavier Estivill; Anne M Bowcock; Gerald G Krueger; Wolfgang Weger; Jane Worthington; Rachid Tazi-Ahnini; Frank O Nestle; Adrian Hayday; Per Hoffmann; Juliane Winkelmann; Cisca Wijmenga; Cordelia Langford; Sarah Edkins; Robert Andrews; Hannah Blackburn; Amy Strange; Gavin Band; Richard D Pearson; Damjan Vukcevic; Chris C A Spencer; Panos Deloukas; Ulrich Mrowietz; Stefan Schreiber; Stephan Weidinger; Sulev Koks; Külli Kingo; Tonu Esko; Andres Metspalu; Henry W Lim; John J Voorhees; Michael Weichenthal; H Erich Wichmann; Vinod Chandran; Cheryl F Rosen; Proton Rahman; Dafna D Gladman; Christopher E M Griffiths; Andre Reis; Juha Kere; Rajan P Nair; Andre Franke; Jonathan N W N Barker; Goncalo R Abecasis; James T Elder; Richard C Trembath
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

6.  Local microbleeding facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells.

Authors:  Masaaki Murakami; Yuko Okuyama; Hideki Ogura; Shogo Asano; Yasunobu Arima; Mineko Tsuruoka; Masaya Harada; Minoru Kanamoto; Yukihisa Sawa; Yoichiro Iwakura; Kiyoshi Takatsu; Daisuke Kamimura; Toshio Hirano
Journal:  J Exp Med       Date:  2011-01-10       Impact factor: 14.307

7.  Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.

Authors:  Shin-ichiro Sawa; Daisuke Kamimura; Gui-Hua Jin; Hideyuki Morikawa; Hokuto Kamon; Mika Nishihara; Katsuhiko Ishihara; Masaaki Murakami; Toshio Hirano
Journal:  J Exp Med       Date:  2006-05-22       Impact factor: 14.307

8.  Psoriatic arthritis: an update.

Authors:  Peter Lloyd; Caitriona Ryan; Alan Menter
Journal:  Arthritis       Date:  2012-10-17

Review 9.  The pathological and physiological roles of IL-6 amplifier activation.

Authors:  Masaaki Murakami; Toshio Hirano
Journal:  Int J Biol Sci       Date:  2012-10-25       Impact factor: 6.580

10.  Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses.

Authors:  Lisa C Zaba; Irma Cardinale; Patricia Gilleaudeau; Mary Sullivan-Whalen; Mayte Suárez-Fariñas; Mayte Suárez Fariñas; Judilyn Fuentes-Duculan; Inna Novitskaya; Artemis Khatcherian; Mark J Bluth; Michelle A Lowes; James G Krueger
Journal:  J Exp Med       Date:  2007-11-26       Impact factor: 14.307

View more
  16 in total

Review 1.  Review: Enthesitis: New Insights Into Pathogenesis, Diagnostic Modalities, and Treatment.

Authors:  Amy S Kehl; Maripat Corr; Michael H Weisman
Journal:  Arthritis Rheumatol       Date:  2016-02       Impact factor: 10.995

Review 2.  Early Recognition and Treatment Heralds Optimal Outcomes: the Benefits of Combined Rheumatology-Dermatology Clinics and Integrative Care of Psoriasis and Psoriatic Arthritis Patients.

Authors:  Teo Soleymani; Soumya M Reddy; Jeffrey M Cohen; Andrea L Neimann
Journal:  Curr Rheumatol Rep       Date:  2017-11-20       Impact factor: 4.592

3.  Editorial: STATus of STAT3 in Psoriatic Arthritis.

Authors:  John D Mountz
Journal:  Arthritis Rheumatol       Date:  2018-05-02       Impact factor: 10.995

Review 4.  Psoriasis: Past, Present, and Future.

Authors:  Allison C Billi; Johann E Gudjonsson; John J Voorhees
Journal:  J Invest Dermatol       Date:  2019-11       Impact factor: 8.551

5.  Epidermal Dysfunction Leads to an Age-Associated Increase in Levels of Serum Inflammatory Cytokines.

Authors:  Lizhi Hu; Theodora M Mauro; Erle Dang; George Man; Jing Zhang; Dale Lee; Gang Wang; Kenneth R Feingold; Peter M Elias; Mao-Qiang Man
Journal:  J Invest Dermatol       Date:  2017-01-20       Impact factor: 8.551

6.  Tristetraprolin expression by keratinocytes controls local and systemic inflammation.

Authors:  Mathieu Andrianne; Assiya Assabban; Caroline La; Denis Mogilenko; Delphine Staumont Salle; Sébastien Fleury; Gilles Doumont; Gaëtan Van Simaeys; Sergei A Nedospasov; Perry J Blackshear; David Dombrowicz; Stanislas Goriely; Laurye Van Maele
Journal:  JCI Insight       Date:  2017-06-02

Review 7.  Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions.

Authors:  Ananta Paine; Christopher Ritchlin
Journal:  Calcif Tissue Int       Date:  2018-01-12       Impact factor: 4.333

8.  The Snowballing Literature on Imiquimod-Induced Skin Inflammation in Mice: A Critical Appraisal.

Authors:  Jason E Hawkes; Johann E Gudjonsson; Nicole L Ward
Journal:  J Invest Dermatol       Date:  2016-12-09       Impact factor: 8.551

Review 9.  Pathophysiology, assessment and treatment of psoriatic dactylitis.

Authors:  Dennis McGonagle; Ai Lyn Tan; Abdulla Watad; Philip Helliwell
Journal:  Nat Rev Rheumatol       Date:  2019-02       Impact factor: 20.543

Review 10.  New Frontiers in Psoriatic Disease Research, Part I: Genetics, Environmental Triggers, Immunology, Pathophysiology, and Precision Medicine.

Authors:  Di Yan; Johann E Gudjonsson; Stephanie Le; Emanual Maverakis; Olesya Plazyo; Christopher Ritchlin; Jose U Scher; Roopesh Singh; Nicole L Ward; Stacie Bell; Wilson Liao
Journal:  J Invest Dermatol       Date:  2021-07-22       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.